RARE - Ultragenyx Pharmaceutical GAAP EPS of -$2.03 misses by $0.28 revenue of $108.8M misses by $7.64M
2024-05-02 16:02:32 ET
More on Ultragenyx Pharmaceutical
- Ultragenyx Pharmaceutical Earnings: No Visible Path To Financial Success Yet
- Ultragenyx Pharmaceutical, Inc. (RARE) Q4 2023 Earnings Call Transcript
- Ultragenyx Pharmaceutical Q1 2024 Earnings Preview
- As more rare disease therapies launch, their prices are rising
- Seeking Alpha’s Quant Rating on Ultragenyx Pharmaceutical